A core needle biopsy is a procedure where a doctor takes a sample from a suspicious lump or area of tissue. The report mainly studies core biopsy needles. LPI (LP Information)' newest research report, the ﾓSoft Tissue Core Biopsy Industry Forecastﾔ looks at past sales and reviews total world Soft Tissue Core Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Soft Tissue Core Biopsy sales for 2023 through 2029. With Soft Tissue Core Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soft Tissue Core Biopsy industry. This Insight Report provides a comprehensive analysis of the global Soft Tissue Core Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soft Tissue Core Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Soft Tissue Core Biopsy market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soft Tissue Core Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soft Tissue Core Biopsy. The global Soft Tissue Core Biopsy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Soft Tissue Core Biopsy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China market for Soft Tissue Core Biopsy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Europe market for Soft Tissue Core Biopsy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Global key Soft Tissue Core Biopsy players cover BD, Medtronic, IZI Medical, Medax, ARGON MEDICAL, Ranfac, Merit Medical and INRAD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022. This report presents a comprehensive overview, market shares, and growth opportunities of Soft Tissue Core Biopsy market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Below 10 cm 10-15 cm 15-20 cm Above 20 cm Segmentation by application Hospitals & Clinics Ambulatory Surgical Centers Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. BD Medtronic IZI Medical Medax ARGON MEDICAL Ranfac Merit Medical INRAD Key Questions Addressed in this Report What is the 10-year outlook for the global Soft Tissue Core Biopsy market? What factors are driving Soft Tissue Core Biopsy market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Soft Tissue Core Biopsy market opportunities vary by end market size? How does Soft Tissue Core Biopsy break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Soft Tissue Core Biopsy Annual Sales 2018-2029 2.1.
